Skip to main content
Medistim logo

Medistim — Investor Relations & Filings

Ticker · MEDI ISIN · NO0010159684 LEI · 5967007LIEEXZXJOX483 OL Manufacturing
Open in API
Filings indexed 783 across all filing types
Latest filing 2019-02-28 Report Publication Anno…
Country NO Norway
Listing OL MEDI

About Medistim

https://medistim.com/

Medistim is a medical technology company specializing in intraoperative quality assessment solutions. A pioneer and market leader in Transit Time Flow Measurement (TTFM), the company develops and manufactures advanced medical devices for use during surgical procedures. Its flagship MiraQ™ system uniquely combines TTFM with high-frequency ultrasound imaging, providing surgeons with real-time data to verify graft function and blood flow. This technology is applied in cardiac, vascular, and transplant surgery to enhance procedural quality control and improve patient outcomes.

Recent filings

Filing Released Lang Actions
Corrected balance sheet for Medistim ASA
Report Publication Announcement Classification · 98% confidence The document text is very short (475 characters) and explicitly states that it is a 'Corrected balance sheet' and refers to an 'Attached is an updated 4th quarter report' and 'See also attached report.' This structure—a brief announcement pointing to an attached or linked document that contains the actual detailed financial information—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS), according to the 'MENU VS MEAL' rule. Since this is specifically about correcting and publishing a financial report (a 4th quarter report), RPA is the most precise fit, as it announces the publication/correction of a report. It is not the full report itself (which would likely be classified as IR if it were comprehensive).
2019-02-28 English
Innsider sells Medistim shares
Director's Dealing Classification · 99% confidence The document text explicitly states that an 'Innsider sells Medistim shares' and details a transaction by 'Helge Børslid, VP Operations,' who sold 1000 shares. This directly relates to personal share transactions by company directors or executives (insider trades). This aligns perfectly with the definition for Director's Dealing (DIRS). The document is very short, but the content is specific enough to classify it directly rather than using the RPA/RNS fallback.
2019-02-28 English
Resultater for Medistim for 4 kvartal og foreløpig resultat for 2018.
Interim / Quarterly Report Classification · 100% confidence The document is a detailed quarterly financial report for Medistim ASA for the fourth quarter of 2018. It contains comprehensive financial statements (Profit and Loss, Balance Sheet), business segment updates, and management analysis of performance. It is not a short announcement or a mere certification, but a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q4 2018
2019-02-27 Norwegian
Results for fourth quarter and preliminary results for Medistim for 2018
Interim / Quarterly Report Classification · 100% confidence The document is a detailed quarterly financial report for Medistim ASA for the fourth quarter of 2018. It contains comprehensive financial statements (Profit and Loss, Balance Sheet), business segment updates, and management analysis of performance. It is not a short announcement or a mere certification, but a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q4 2018
2019-02-27 English
Resultater for Medistim for 4 kvartal og foreløpig resultat for 2018.
Earnings Release Classification · 99% confidence The document is titled "4. kvartal og foreløpig årsregnskap 2018" (4th quarter and preliminary annual accounts 2018) and contains detailed financial figures for the fourth quarter and the full year 2018, including revenue, EBIT, balance sheet items, and earnings per share. It explicitly mentions being prepared according to IFRS and IAS 34 for interim reporting. This structure and content strongly indicate a comprehensive financial report covering a period shorter than a full year (quarterly/interim report) or a preliminary annual report that is not the final audited 10-K. Since it covers the full year results preliminarily and is comprehensive, it fits the definition of an Interim/Quarterly Report (IR) better than a simple Earnings Release (ER), which is usually just highlights. Given the depth of financial detail and the reference to 'foreløpig årsregnskap' (preliminary annual accounts), it is a comprehensive period report. The closest fit among the provided codes for a detailed, non-10-K annual/period report is 'IR' (Interim / Quarterly Report). Q4 2018
2019-02-27 Norwegian
Results for fourth quarter and preliminary results for Medistim for 2018
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the fourth quarter and full year 2018. It contains detailed financial statements, including sales, EBIT, earnings per share, balance sheet data, and operational status across different geographic regions. It is not an announcement of a report (RPA) nor a simple earnings release (ER), as it provides in-depth analysis and substantive financial data consistent with an interim/quarterly report. Q4 2018
2019-02-27 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.